Trial Title:
Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)
NCT ID:
NCT05607550
Condition:
Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer
EGFR Exon 20 Mutations
Conditions: Official terms:
Lung Neoplasms
Carcinoma, Non-Small-Cell Lung
Aflutinib
Conditions: Keywords:
Non-Small Cell Lung Cancer (NSCLC)
Exon 20
Furmonertinib
Firmonertinib
AST2818
FURMO-004
Drug-Therapy
Study type:
Interventional
Study phase:
Phase 3
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Drug
Intervention name:
furmonertinib 240 mg oral, daily
Description:
furmonertinib tablet
Arm group label:
furmonertinib 240 mg
Other name:
AST2818
Intervention type:
Drug
Intervention name:
furmonertinib 160 mg oral, daily
Description:
furmonertinib tablet
Arm group label:
furmonertinib 160 mg
Other name:
AST2818
Intervention type:
Drug
Intervention name:
platinum-based chemotherapy
Description:
(carboplatin or cisplatin based on investigator's choice) + pemetrexed intravenously (IV)
Arm group label:
platinum-based chemotherapy
Summary:
Global, Phase 3, randomized, multicenter, open-label study evaluating the efficacy and
safety of furmonertinib (firmonertinib) at 2 dose levels (160 mg once daily [QD] and 240
mg QD) compared to platinum-based chemotherapy in previously untreated patients with
locally advanced or metastatic non-squamous Non-Small Cell Lung Cancer (NSCLC) with
Epidermal Growth Factor Receptor (EGFR) exon 20 insertion mutations. A target of
approximately 375 patients will be randomized in a 1:1:1 ratio to treatment with
furmonertinib 240 mg QD, furmonertinib 160 mg QD, or platinum-based chemotherapy.
Criteria for eligibility:
Criteria:
Key Inclusion Criteria:
- Histologically or cytologically documented, locally advanced or metastatic
non-squamous Non-Small Cell Lung Cancer (NSCLC) not amenable to curative surgery or
radiotherapy.
- Documented results of the presence of an Epidermal Growth Factor Receptor (EGFR)
exon 20 insertion mutation in tumor tissue or blood from local or central testing.
- No prior systemic anticancer therapy regimens received for locally advanced or
metastatic Non-Small Cell Lung Cancer (NSCLC) including prior treatment with any
Epidermal Growth Factor Receptor (EGFR)-targeting agents (e.g., previous (EGFR)
TKIs, monoclonal antibodies, or bispecific antibodies).
- Patients who have received prior neo-adjuvant and/or adjuvant chemotherapy,
immunotherapy, or chemo radiotherapy for non-metastatic disease (excluding
EGFR-TKIs) must have experienced a treatment free interval of at least 12 months.
- Patients with a history of treated CNS metastases or new asymptomatic CNS metastases
are eligible.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Daphne
Zip:
36526
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Yuma
Zip:
85364
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Fayetteville
Zip:
72703
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Beverly Hills
Zip:
90212
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Fullerton
Zip:
92835
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Long Beach
Zip:
90806
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Los Alamitos
Zip:
90720
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Napa
Zip:
94558
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Orange
Zip:
90868
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Orange
Zip:
92868
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative site
Address:
City:
Sacramento
Zip:
95817
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
San Diego
Zip:
92123
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Santa Barbara
Zip:
93105
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Santa Monica
Zip:
90404
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Santa Rosa
Zip:
95403
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Whittier
Zip:
90602
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Hartford
Zip:
06102
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Norwich
Zip:
06360
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Fort Myers
Zip:
33901
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Saint Petersburg
Zip:
33705
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
The Villages
Zip:
32159
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Peoria
Zip:
61615
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Rolling Meadows
Zip:
60008
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Fort Wayne
Zip:
46804
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Indianapolis
Zip:
46250
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
South Bend
Zip:
46601
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Bethesda
Zip:
20817
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Frederick
Zip:
21702
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Rockville
Zip:
20850
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Fairhaven
Zip:
02719
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Lansing
Zip:
48912
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Bolivar
Zip:
65613
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Kansas City
Zip:
64111
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Saint Joseph
Zip:
64507
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Saint Louis
Zip:
63110
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Omaha
Zip:
68114
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Belleville
Zip:
07109
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Englewood
Zip:
07631
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Florham Park
Zip:
07932
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Bronx
Zip:
10461
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Goldsboro
Zip:
27534
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Pinehurst
Zip:
28374
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Canton
Zip:
44708
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Cincinnati
Zip:
45220
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Cincinnati
Zip:
45242
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Cleveland
Zip:
44195
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Columbus
Zip:
43214
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Oklahoma City
Zip:
73102
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Tulsa
Zip:
74146
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Salem
Zip:
97301
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Gettysburg
Zip:
17325
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Langhorne
Zip:
19047
Country:
United States
Status:
Recruiting
Contact:
Last name:
ArriVent I Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
York
Zip:
17403
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Greenville
Zip:
29607
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Sioux Falls
Zip:
57117
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Memphis
Zip:
38120
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Nashville
Zip:
37203
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Abilene
Zip:
79606
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Austin
Zip:
78745
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Houston
Zip:
77030
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Plano
Zip:
75093
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Ogden
Zip:
84405
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Salt Lake City
Zip:
84106
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Fairfax
Zip:
22031
Country:
United States
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Fredericksburg
Zip:
22408
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Bellingham
Zip:
98225
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Spokane Valley
Zip:
99216
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Tacoma
Zip:
98405
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Appleton
Zip:
54911
Country:
United States
Status:
Enrolling by invitation
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Heidelberg
Zip:
3084
Country:
Australia
Status:
Not yet recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Blacktown
Zip:
2148
Country:
Australia
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
St Leonards
Zip:
NSW 2065
Country:
Australia
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Woolloongabba
Zip:
4102
Country:
Australia
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Salvador
Zip:
40170-110
Country:
Brazil
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Belo Horizonte
Zip:
30130-090
Country:
Brazil
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Porto Alegre
Zip:
90035-903
Country:
Brazil
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Rio De Janeiro
Zip:
20231-050
Country:
Brazil
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Rio De Janeiro
Zip:
22281-100
Country:
Brazil
Status:
Recruiting
Contact:
Last name:
ArriVent
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Pelotas
Zip:
96020-080
Country:
Brazil
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
São José Do Rio Preto
Zip:
15090-000
Country:
Brazil
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
São Paulo
Zip:
01321-001
Country:
Brazil
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Blumenau
Zip:
89015-200
Country:
Brazil
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Liberdade
Zip:
01509-010
Country:
Brazil
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Taubaté
Zip:
12030-200
Country:
Brazil
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Porto Alegre
Zip:
91350-200
Country:
Brazil
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Toronto
Zip:
M5G 1Z5
Country:
Canada
Status:
Recruiting
Contact:
Last name:
ArriVent Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Beijing
Zip:
101149
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Xuhui
Zip:
200030
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Hangzhou
Zip:
310018
Country:
China
Status:
Recruiting
Contact:
Last name:
Allist I Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Cangzhou
Zip:
061011
Country:
China
Status:
Recruiting
Contact:
Last name:
Allist I Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Shushan
Zip:
230022
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Zhengzhou
Zip:
450052
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Changchun
Zip:
130000
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Weihai
Zip:
264200
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Meijiang
Zip:
514000
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Nanning
Zip:
530000
Country:
China
Status:
Recruiting
Contact:
Last name:
ArriVent Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Yangpu
Zip:
200433
Country:
China
Status:
Recruiting
Contact:
Last name:
Allist I Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Xi'an
Zip:
710061
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Taiyuan
Zip:
030013
Country:
China
Status:
Recruiting
Contact:
Last name:
Allist I Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Kunming
Zip:
650100
Country:
China
Status:
Recruiting
Contact:
Last name:
ArriVent Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Zhejiang
Zip:
310022
Country:
China
Status:
Recruiting
Contact:
Last name:
ArriVent Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Anyang
Zip:
455001
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Changchun
Zip:
130000
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Changsha
Zip:
410008
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Changsha
Zip:
410031
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Chengdu
Zip:
610041
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Chenzhou
Zip:
423099
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Chongqing
Zip:
400030
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Guangzhou
Zip:
510062
Country:
China
Status:
Recruiting
Contact:
Last name:
Site 156044
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Guangzhou
Zip:
510285
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Harbin
Zip:
150081
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Hefei
Zip:
230088
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Huai'an
Zip:
223300
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Huizhou
Zip:
516000
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Jinan
Zip:
250013
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Jinan
Zip:
250117
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Jining
Zip:
272000
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Lanzhou
Zip:
730030
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Lishui
Zip:
323020
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Luoyang
Zip:
471000
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Nanchang
Zip:
330006
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Nanchang
Zip:
330046
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Nanjing
Zip:
210009
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Ningbo
Zip:
315040
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Shanghai
Zip:
200434
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Shantou
Zip:
515031
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Shenyang
Zip:
110042
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Shenzhen
Zip:
518001
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Taiyuan
Zip:
030000
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Tianjin
Zip:
300061
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Weihui
Zip:
453000
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Wuhan
Zip:
430023
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Xiamen
Zip:
361000
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Xianyang
Zip:
441138
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Xinxiang
Zip:
453000
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Xuzhou
Zip:
221009
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Allist Investigative Site
Address:
City:
Zhengzhou
Zip:
450003
Country:
China
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Caen
Zip:
14000
Country:
France
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Lyon
Zip:
69003
Country:
France
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Lyon
Zip:
69008
Country:
France
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Marseille
Zip:
13915
Country:
France
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Toulouse
Zip:
31059
Country:
France
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Villejuif
Zip:
94800
Country:
France
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Be'er Sheva
Zip:
8410101
Country:
Israel
Status:
Recruiting
Contact:
Last name:
ArriVent Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Haifa
Zip:
3109601
Country:
Israel
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Jerusalem
Zip:
9103102
Country:
Israel
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Rozzano
Zip:
20089
Country:
Italy
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Aviano
Zip:
33081
Country:
Italy
Status:
Recruiting
Contact:
Last name:
ArriVent Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Roma
Zip:
00144
Country:
Italy
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Bari
Zip:
70124
Country:
Italy
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Meldola
Zip:
47014
Country:
Italy
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Milano
Zip:
20141
Country:
Italy
Status:
Recruiting
Contact:
Last name:
ArriVent
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Kurume
Zip:
830-0011
Country:
Japan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Akashi
Zip:
673-8558
Country:
Japan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Hirakata
Zip:
573-1191
Country:
Japan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Kashiwa
Zip:
277-8577
Country:
Japan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Nagoya
Zip:
460-0001
Country:
Japan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Sapporo-shi
Zip:
003-0804
Country:
Japan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Sendai
Zip:
980-0873
Country:
Japan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Shizuoka
Zip:
4118777
Country:
Japan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Tokyo
Zip:
113-8431
Country:
Japan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Tokyo
Zip:
113-8677
Country:
Japan
Status:
Recruiting
Contact:
Last name:
ArriVent Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Ube
Zip:
755-0241
Country:
Japan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Yokohama
Zip:
241-8515
Country:
Japan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Ōsaka-sayama
Zip:
589-8511
Country:
Japan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Jungni I Gu
Zip:
03181
Country:
Korea, Republic of
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Busan
Zip:
49241
Country:
Korea, Republic of
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Hwasun
Zip:
58128
Country:
Korea, Republic of
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Seoul
Zip:
2447
Country:
Korea, Republic of
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Seoul
Zip:
3722
Country:
Korea, Republic of
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Seoul
Zip:
5505
Country:
Korea, Republic of
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Seoul
Zip:
6351
Country:
Korea, Republic of
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
George Town
Zip:
10990
Country:
Malaysia
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Cheras
Zip:
56000
Country:
Malaysia
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Kota Bharu
Zip:
15586
Country:
Malaysia
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Kuala Lumpur
Zip:
50586
Country:
Malaysia
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Kuching
Zip:
93586
Country:
Malaysia
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Ciudad de mexico
Zip:
14080
Country:
Mexico
Status:
Recruiting
Contact:
Last name:
ArriVent I Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Tuxtla Gutiérrez
Zip:
29038
Country:
Mexico
Status:
Recruiting
Contact:
Last name:
ArriVent I Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Amsterdam
Zip:
1066 CX
Country:
Netherlands
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Harderwijk
Zip:
3844DG
Country:
Netherlands
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Cebu
Zip:
6000
Country:
Philippines
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Davao City
Zip:
8000
Country:
Philippines
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Manila
Zip:
1000
Country:
Philippines
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Pasig
Zip:
1600
Country:
Philippines
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Singapore
Zip:
119074
Country:
Singapore
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Singapore
Zip:
169610
Country:
Singapore
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Málaga
Zip:
29011
Country:
Spain
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
A Coruña
Zip:
15006
Country:
Spain
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Barcelona
Zip:
08035
Country:
Spain
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Madrid
Zip:
28020
Country:
Spain
Status:
Recruiting
Contact:
Last name:
ArriVent Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Valencia
Zip:
46026
Country:
Spain
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Chang Hua
Zip:
50006
Country:
Taiwan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Kaohsiung
Zip:
807
Country:
Taiwan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Kaohsiung
Zip:
82445
Country:
Taiwan
Status:
Recruiting
Contact:
Last name:
ArriVent Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Taichung
Zip:
407219
Country:
Taiwan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Tainan
Zip:
704
Country:
Taiwan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Taipei
Zip:
10048
Country:
Taiwan
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Bangkok
Zip:
10210
Country:
Thailand
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Bangkok
Zip:
10330
Country:
Thailand
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Bangkok
Zip:
10400
Country:
Thailand
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Hat Yai
Zip:
90110
Country:
Thailand
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Guildford
Zip:
GU2 7XX
Country:
United Kingdom
Status:
Recruiting
Contact:
Last name:
ArriVent Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
Arrivent Investigative Site
Address:
City:
Bebington
Zip:
CH63 4JY
Country:
United Kingdom
Status:
Recruiting
Contact:
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
London
Zip:
SW3 6JJ
Country:
United Kingdom
Status:
Recruiting
Contact:
Last name:
ArriVent I Site
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Manchester
Zip:
M20 4BX
Country:
United Kingdom
Status:
Recruiting
Contact:
Last name:
ArriVent
Email:
FURMO004CT@arrivent.com
Facility:
Name:
ArriVent Investigative Site
Address:
City:
Sutton
Zip:
SM2 5PT
Country:
United Kingdom
Status:
Recruiting
Contact:
Last name:
ArriVent I Site
Email:
FURMO004CT@arrivent.com
Start date:
June 1, 2023
Completion date:
February 15, 2028
Lead sponsor:
Agency:
ArriVent BioPharma, Inc.
Agency class:
Industry
Collaborator:
Agency:
Allist Pharmaceuticals, Inc.
Agency class:
Industry
Source:
ArriVent BioPharma, Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05607550
